Global Human Milk Oligosaccharides Market
Market Size in USD Billion
CAGR :
% 
USD
40.50 Billion
USD
198.91 Billion
2024
2032
 Forecast Period |
2025 –2032 |
 Market Size (Base Year) |
USD 40.50 Billion |
 Market Size (Forecast Year) |
USD 198.91 Billion |
 CAGR |
% |
| Major Markets Players |
Global Human Milk Oligosaccharides (HMOs) Market Segmentation, By Type (2’FL, 3’FL, 3’SL, 6’SL), Product (Fucosyllactose, LNT & LNnT, Sialyllactose), Application (Infant Formula, Functional Food & Beverages, Food Supplements, Health Ingredients for Human and Animal, Others) Distribution Channel (Hypermarkets & Supermarkets, Drug Store or Pharmacy, Mass Merchandiser, Departmental Stores, Mono-brand Stores, Specialty Stores, and Online Sales Channel) – Industry Trends and Forecast to 2032
Human Milk Oligosaccharides (HMOs) Market Analysis
Human Milk Oligosaccharides (HMOs) are beneficial to immunity, key players in the human milk oligosaccharides (HMO) market are developing new techniques to produce them , such as extracting HMO from cow milk, using expensive procedures (chemical or enzymatic synthesis), or using microbes. Market products containing human milk oligosaccharides (HMO) are expensive because a large amount of human milk is synthesized to produce a small HMO. As a result of continual research and development, synthesis and extraction procedures are improving.
Human Milk Oligosaccharides (HMOs) Market Size
Global human milk oligosaccharides (HMOs) market size was valued at USD 40.50 billion in 2024 and is projected to reach USD 198.91 billion by 2032, with a CAGR of 22.01% during the forecast period of 2025 to 2032.
Report Scope and Market Segmentation
|
Attributes |
Human Milk Oligosaccharides (HMOs) Key Market Insights |
|
Segmentation |
|
|
Countries Covered |
U.S., Canada and Mexico in North America, Germany, Sweden, Poland, Denmark, Italy, France, Netherlands, U.K., Switzerland, Belgium, Russia, Italy, Spain, Turkey, Rest of Europe in Europe, China, Japan, India, South Korea, Singapore, Malaysia, Australia, Thailand, Indonesia, Philippines, Rest of Asia-Pacific (APAC) in the Asia-Pacific (APAC), Saudi Arabia, U.A.E, South Africa, Egypt, Israel, Rest of Middle East and Africa (MEA) as a part of Middle East and Africa (MEA), Brazil, Argentina and Rest of South America as part of South America |
|
Key Market Players |
ZuChem Inc. (U.S), Elicityl SA (France), Jennewein Biotechnologie GmbH (Germany), Royal FrieslandCampina NV (Netherlands), BASF SE (Germany), Gnubiotics (Switzerland), DuPont Nutrition & Health (Denmark), Inbiose NV (Belgium), Glycom A/S (Denmark), Glycosyn LLC (U.S.) |
|
Market Opportunities |
|
Human Milk Oligosaccharides (HMOs) Market Definition
HMOs are prebiotics that is naturally found in a mother's breast milk. After fat and carbohydrates, they are the most abundant solid ingredient in breast milk. HMOs have been shown in studies to benefit the microbiome of breastfed babies.
Human Milk Oligosaccharides (HMOs) Market Dynamics
Drivers
- Rising demand for dietary supplements
Increasing demand for dietary supplements, improvement in metabolic activity by promoting bacterial growth, and an increase in the number of applications from pharmaceuticals, infant formulas, and medicinal foods are some of the factors that will drive the growth of the human milk oligosaccharides market
- Benefits in brain development and memory enhancement
It aids in brain development and memory enhancement, which will increase the number of opportunities for the human milk oligosaccharides market during the forecast period.
Opportunity
For a long time, HMOs have been used in infant formula and human milk. However, the compositions differ, and HMOs are not found in other foods. The approach to the market for new and novel Human Milk Oligosaccharides (HMOs) as a dietary supplement is to get GRAS self-affirmed for use in food and then utilise it as a dietary supplement. Such notices have been issued for 2'-O-fucosyllactose, 2'-fucosyllactose, and lacto-N-neotetraose.
Restraints
The lack of technology for large-scale production and stringent regulations and high development costs will stymie the growth of the human milk oligosaccharides market during the forecast period.
This human milk oligosaccharides (HMOs) market report provides details of new recent developments, trade regulations, import-export analysis, production analysis, value chain optimization, market share, impact of domestic and localized market players, analyses opportunities in terms of emerging revenue pockets, changes in market regulations, strategic market growth analysis, market size, category market growths, application niches and dominance, product approvals, product launches, geographic expansions, technological innovations in the market. To gain more info on the human milk oligosaccharides (HMOs) market contact Data Bridge Market Research for an Analyst Brief, our team will help you take an informed market decision to achieve market growth.
Human Milk Oligosaccharides (HMOs) Market Scope
The human milk oligosaccharides (HMOs) market is segmented on the basis of type, product type, distribution channel an application. The growth amongst these segments will help you analyze meagre growth segments in the industries and provide the users with a valuable market overview and market insights to help them make strategic decisions for identifying core market applications.
Type
- 2’FL
- 3’FL
- 3’SL
- 6’SL
Product
- Fucosyllactose
- Lnt & LNnt
- Sialyllactose
Application
- Infant formula
- Functional food & beverages
- Food supplements
- Health ingredients for human and animal
- Other
Distribution channel
- Hypermarkets and supermarkets
- Drug store or pharmacy
- Mass merchandiser
- Departmental stores
- Mono-brand stores
- Specialty stores
- Online sales channel
Human Milk Oligosaccharides (HMOs) Market Regional Analysis
The human milk oligosaccharides (HMOs) market is analyzed and market size insights and trends are provided by country, type, product type and application as referenced above.
The countries covered in the human milk oligosaccharides (HMOs) market report are U.S., Canada and Mexico in North America, Germany, Sweden, Poland, Denmark, Italy, France, U.K., Netherlands, Switzerland, Belgium, Russia, Italy, Spain, Turkey, Rest of Europe in Europe, China, Japan, India, South Korea, Singapore, Malaysia, Australia, Thailand, Indonesia, Philippines, Rest of Asia-Pacific (APAC) in the Asia-Pacific (APAC), Saudi Arabia, U.A.E, South Africa, Egypt, Israel, Rest of Middle East and Africa (MEA) as a part of Middle East and Africa (MEA), Brazil, Argentina and Rest of South America as part of South America.
Europe dominates the HMOs, with Germany likely to be a large country-level market contributing to the expansion of the European market. Because of increased health consciousness among consumers in the region, the Asia-Pacific market is expected to grow fastest during the forecast period.
The country section of the report also provides individual market impacting factors and changes in market regulation that impact the current and future trends of the market. Data points like down-stream and upstream value chain analysis, technical trends and porter's five forces analysis, case studies are some of the pointers used to forecast the market scenario for individual countries. Also, the presence and availability of global brands and their challenges faced due to large or scarce competition from local and domestic brands, impact of domestic tariffs and trade routes are considered while providing forecast analysis of the country data.
Human Milk Oligosaccharides (HMOs) Market Share
The human milk oligosaccharides (HMOs) market competitive landscape provides details by competitor. Details included are company overview, company financials, revenue generated, market potential, investment in research and development, new market initiatives, global presence, production sites and facilities, production capacities, company strengths and weaknesses, product launch, product width and breadth, application dominance. The above data points provided are only related to the companies' focus related to human milk oligosaccharides (HMOs) market.
Human Milk Oligosaccharides (HMOs) Market Leaders Operating in the Market Are:
- ZuChem Inc. (U.S)
- Elicityl SA (France)
- Jennewein Biotechnologie GmbH (Germany)
- Royal FrieslandCampina NV (Netherlands)
- BASF SE (Germany)
- Gnubiotics (Switzerland)
- DuPont Nutrition & Health (Denmark)
- Inbiose NV (Belgium)
- Glycom A/S (Denmark)
- Glycosyn LLC (U.S.)
Latest Developments in Human Milk Oligosaccharides (HMOs) Market
- Over the years, prominent market participants have invested in R&D activities to innovate their product offerings. For example, Jennewein Biotechnologie GmbH, a functional sugars manufacturer based in Germany, collaborated with Yili.Com Inc., a dairy products manufacturer based in China, in February 2019 to research infant microbiome and human milk oligosaccharides. This strategy was designed to develop innovative, HMO-based infant formula for Chinese customers. Given the increasing market competition, such developments/strategies are likely to emerge during the forecast period
SKU-
Get online access to the report on the World's First Market Intelligence Cloud
- Interactive Data Analysis Dashboard
- Company Analysis Dashboard for high growth potential opportunities
- Research Analyst Access for customization & queries
- Competitor Analysis with Interactive dashboard
- Latest News, Updates & Trend analysis
- Harness the Power of Benchmark Analysis for Comprehensive Competitor Tracking
Global Human Milk Oligosaccharides Market, Supply Chain Analysis and Ecosystem Framework
To support market growth and help clients navigate the impact of geopolitical shifts, DBMR has integrated in-depth supply chain analysis into its Global Human Milk Oligosaccharides Market research reports. This addition empowers clients to respond effectively to global changes affecting their industries. The supply chain analysis section includes detailed insights such as Global Human Milk Oligosaccharides Market consumption and production by country, price trend analysis, the impact of tariffs and geopolitical developments, and import and export trends by country and HSN code. It also highlights major suppliers with data on production capacity and company profiles, as well as key importers and exporters. In addition to research, DBMR offers specialized supply chain consulting services backed by over a decade of experience, providing solutions like supplier discovery, supplier risk assessment, price trend analysis, impact evaluation of inflation and trade route changes, and comprehensive market trend analysis.
Research Methodology
Data collection and base year analysis are done using data collection modules with large sample sizes. The stage includes obtaining market information or related data through various sources and strategies. It includes examining and planning all the data acquired from the past in advance. It likewise envelops the examination of information inconsistencies seen across different information sources. The market data is analysed and estimated using market statistical and coherent models. Also, market share analysis and key trend analysis are the major success factors in the market report. To know more, please request an analyst call or drop down your inquiry.
The key research methodology used by DBMR research team is data triangulation which involves data mining, analysis of the impact of data variables on the market and primary (industry expert) validation. Data models include Vendor Positioning Grid, Market Time Line Analysis, Market Overview and Guide, Company Positioning Grid, Patent Analysis, Pricing Analysis, Company Market Share Analysis, Standards of Measurement, Global versus Regional and Vendor Share Analysis. To know more about the research methodology, drop in an inquiry to speak to our industry experts.
Customization Available
Data Bridge Market Research is a leader in advanced formative research. We take pride in servicing our existing and new customers with data and analysis that match and suits their goal. The report can be customized to include price trend analysis of target brands understanding the market for additional countries (ask for the list of countries), clinical trial results data, literature review, refurbished market and product base analysis. Market analysis of target competitors can be analyzed from technology-based analysis to market portfolio strategies. We can add as many competitors that you require data about in the format and data style you are looking for. Our team of analysts can also provide you data in crude raw excel files pivot tables (Fact book) or can assist you in creating presentations from the data sets available in the report.
